Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Japanese Journal of Clinical Oncology|June 16, 2023
Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatmentHiroshi Imaoka, Masafumi Ikeda, Kumiko Umemoto, et al.
Plos One|September 8, 2018
Prediction model for pancreatic cancer risk in the general Japanese populationMasahiro Nakatochi, Yingsong Lin, Hidemi Ito, et al.
Scientific Reports|October 1, 2025
Impact of ERCC1 on the outcomes of chemotherapy in advanced biliary tract cancerYasunari Sakamoto, Chigusa Morizane, Takuji Okusaka, et al.
International Journal of Clinical Oncology|October 23, 2024
Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113Tatsuya Okuno, Chigusa Morizane, Junki Mizusawa, et al.
Journal of Hepatology|March 28, 2025
Health-related quality of life in participants with advanced biliary tract cancer from the randomized phase III KEYNOTE-966 studyChanghoon Yoo, Makoto Ueno, Heinz-Josef Klümpen, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 18, 2014
Lack of associations between genetic polymorphisms in GSTM1, GSTT1 and GSTP1 and pancreatic cancer risk: a multi-institutional case-control study in JapanIkuhiro Yamada, Masato Matsuyama, Masato Ozaka, et al.
British Journal of Cancer|August 28, 2024
Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancerKentaro Sudo, Yoshiaki Nakamura, Makoto Ueno, et al.
Japanese Journal of Clinical Oncology|November 9, 2020
Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106Tatsuya Ioka, Junji Furuse, Akira Fukutomi, et al.
Neuroendocrinology|September 26, 2025
Multicenter Retrospective Study of Efficacy of Systemic Therapy in Patients with Neuroendocrine Tumor Grade 3 (JOSC-2001)Hiroyuki Okuyama, Taro Shibuki, Naohiro Okano, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2023
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)Masato Ozaka, Kohei Nakachi, Satoshi Kobayashi, et al.
Pageof 18